Systemic exertion intolerance disease/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study. — CFSMEATLAS
Systemic exertion intolerance disease/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study.
Maness, Caroline, Saini, Prabhjyot, Bliwise, Donald L et al. · Journal of sleep research · 2019 · DOI
Quick Summary
This study looked at people visiting sleep clinics who reported excessive daytime sleepiness and found that 21% of them also met criteria for ME/CFS (systemic exertion intolerance disease). People with both conditions reported more severe fatigue and were less likely to benefit from standard wake-promoting medications compared to those with only sleep disorders. The findings suggest that ME/CFS frequently occurs alongside sleep disorders and may make treatment more difficult.
Why It Matters
This research highlights that ME/CFS is a common co-morbidity in sleep clinic populations and may be underrecognized. The finding that ME/CFS patients respond poorly to standard sleep disorder treatments suggests that ME/CFS requires distinct clinical approaches and underscores the importance of screening for post-exertional malaise and exertional intolerance in fatigued patients.
Observed Findings
21% of hypersomnolent patients met ME/CFS criteria
ME/CFS frequency did not significantly differ across five different hypersomnolence diagnostic categories (p = .37)
Patients with both ME/CFS and hypersomnolence reported significantly more profound fatigue than those with hypersomnolence alone
Patients with ME/CFS were less likely to respond to wake-promoting medications (11.4% non-response vs 32.3% in those without ME/CFS; p = .01)
ME/CFS and non-ME/CFS groups did not differ by gender, age, Epworth Sleepiness Scale scores, depressive symptoms, or sleep study parameters
Inferred Conclusions
ME/CFS is a common co-morbidity in hypersomnolent patients that crosses diagnostic boundaries within sleep disorders
The presence of ME/CFS may indicate a poorer prognosis for treatment response with traditional wake-promoting medications
ME/CFS in sleep clinic populations may be clinically occult and warrant systematic screening
Remaining Questions
What biological mechanisms underlie the co-occurrence of ME/CFS and hypersomnolence disorders?
Do alternative treatment approaches (e.g., activity pacing, energy management) improve outcomes in patients with both conditions?
What This Study Does Not Prove
This study does not establish that sleep disorders cause ME/CFS or vice versa—only that they frequently co-occur. The retrospective methodology and reliance on questionnaires rather than standardized ME/CFS diagnostic criteria limit diagnostic precision. The findings do not explain the biological mechanisms linking these conditions or determine optimal treatment strategies for patients with both diagnoses.
What is the temporal relationship between these conditions—do they develop simultaneously or does one precede the other?
How do standard ME/CFS diagnostic criteria (including post-exertional malaise assessment) perform in sleep clinic populations using prospective evaluation?